Indeed, CRP-upregulated CCL2 and IL-6 expression was both CD32 /CD64-dependent as neutralizing antibodies to either CD32 or CD64 blocked both CCL2 and IL-6 expression by RA-FLSs. The gene discussed is CRP; the disease is rheumatoid arthritis.